Jupiter Wellness’ JW-100 Enters Clinical Trial for the Treatment of Herpes

Marks Jupiter’s 3rd Clinical Indication Including Eczema and Burns Study Data to Be Used in Planned IND Filing With U.S. FDA JUPITER, FL / ACCESSWIRE / November 17, 2020 /Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced it has initiated an exploratory clinical study in […]

Investor Alerts

Get our news

For up-to-date company news delivered straight to your inbox or phone, sign up for Investor Alerts today.

To receive alerts via text message, send JUPW to
 +1 (844) 819-8138